Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
4.5K
Affinity and Avidity01:41

Affinity and Avidity

39.2K
Overview
39.2K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

19.9K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
19.9K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.2K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.2K
Protein Networks02:26

Protein Networks

4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cationic imidazolium macrocycles enable array-based, site-selective optical detection of peptide phosphorylation.

Organic & biomolecular chemistry·2026
Same author

Revealing Imatinib-Kinase Specificity via Analyzing Changes in Protein Dynamics and Computing Molecular Binding Affinity.

The journal of physical chemistry. B·2026
Same author

IEPDYN: Integral-equation formalism of population dynamics.

The Journal of chemical physics·2026
Same author

Structural insight into hierarchical DNMT3A autoinhibition and its dysregulation in disease.

Nature communications·2026
Same author

Mesostructured Water Enhances Stability of ProteinMPNN-Designed Ubiquitin-Fold Proteins.

Journal of the American Chemical Society·2026
Same author

Glutathionylated DNA adducts accumulate in mitochondrial DNA and are regulated by AP endonuclease 1 and tyrosyl-DNA phosphodiesterase 1.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Feb 13, 2026

Comparing the Affinity of GTPase-binding Proteins using Competition Assays
10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.7K

Revealing imatinib-kinase specificity via analyzing changes in protein dynamics and computing molecular binding

William Troxel, Emily Vig, Chia-En Chang

    Biorxiv : the Preprint Server for Biology
    |February 12, 2026
    PubMed
    Summary

    Drug promiscuity allows repurposing drugs like imatinib for new treatments. This study reveals how imatinib binds to different kinases by analyzing protein networks and motions, aiding future drug design.

    More Related Videos

    Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
    10:22

    Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

    Published on: August 15, 2013

    31.4K
    Analyzing Melts and Fluids from Ab Initio Molecular Dynamics Simulations with the UMD Package
    06:37

    Analyzing Melts and Fluids from Ab Initio Molecular Dynamics Simulations with the UMD Package

    Published on: September 17, 2021

    5.1K

    Related Experiment Videos

    Last Updated: Feb 13, 2026

    Comparing the Affinity of GTPase-binding Proteins using Competition Assays
    10:37

    Comparing the Affinity of GTPase-binding Proteins using Competition Assays

    Published on: October 8, 2015

    9.7K
    Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
    10:22

    Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

    Published on: August 15, 2013

    31.4K
    Analyzing Melts and Fluids from Ab Initio Molecular Dynamics Simulations with the UMD Package
    06:37

    Analyzing Melts and Fluids from Ab Initio Molecular Dynamics Simulations with the UMD Package

    Published on: September 17, 2021

    5.1K

    Area of Science:

    • Biochemistry
    • Computational Biology
    • Pharmacology

    Background:

    • Drug promiscuity, where a single drug targets multiple proteins, offers therapeutic potential but poses challenges in understanding binding mechanisms.
    • Imatinib, a successful targeted therapy, exhibits varied affinities for different kinases, yet its precise binding determinants remain elusive.
    • Understanding kinase binding specificity is crucial for drug repurposing and designing novel therapeutics.

    Purpose of the Study:

    • To elucidate the molecular determinants governing imatinib's binding specificity across various kinases.
    • To develop a predictive computational approach for forecasting drug-kinase interactions.
    • To explore the potential of drug repurposing by understanding off-target binding mechanisms.

    Main Methods:

    • All-atom molecular dynamics simulations in explicit solvent were employed.
    • Analyses included molecular thermodynamics, force distribution, residue sidechain dihedral correlations, and principal component analysis.
    • Protein-ligand interaction networks and kinase "breathing motions" were investigated.

    Main Results:

    • Computational findings align with experimental data on imatinib affinity and binding.
    • A global protein network analysis successfully predicted imatinib's binding specificity.
    • Changes in sidechain correlations and secondary motif dynamics correlate with binding affinity.

    Conclusions:

    • Residue correlation, force interactions, and principal components effectively predict imatinib-kinase binding specificity.
    • This study provides a framework for repurposing existing drugs and designing new high-affinity binders.
    • Understanding dynamic protein-ligand interactions is key to optimizing drug efficacy and minimizing off-target effects.